MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
CALT
Stock ticker:
PRICE
CHANGE
CAPITALIZATION

Calliditas Therapeutics AB (CALT) Ownership - Who owns Calliditas Therapeutics AB?

Calliditas Therapeutics AB is a commercial-stage biopharma company focused on identifying, developing, and commercializing novel treatments in orphan indications, initially focusing on renal and hepatic diseases with unmet medical needs... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
Kungsbron 1, D5
Phone
+46 84113005
Employees
86
Web
https://www.calliditas.se

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.1B
P/E Ratio
N/A
Total Cash
797.28M
Projected Growth
N/A
Total Debt
1.01B
Revenue
1.6B
Risk (Beta)
1.69
Dividend Yield
N/A
Total Cash/Share
29.51
Total Debt/Equity
N/A
Revenue/Share
5.89 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for CALT
A.I. Advisor
published General Information

General Information

a provider of pharmaceutical products for patients with niche indications

Industry Biotechnology

Profile
Details
Industry
N/A
Address
Kungsbron 1, D5
Phone
+46 84113005
Employees
86
Web
https://www.calliditas.se